ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 0085

Closing the Gender Gap in Global Rheumatology Leadership- Are We There Yet?

Tayyeba Khursheed1, Pavel Ovseiko2, Ghita Harifi3, Humeira Badsha4, Harish G Shekar5 and Latika Gupta6, 1Pakistan Institute of Medical Sciences, Islamabad, Pakistan, 2John Radcliffe Hospital, Oxford, Oxford, United Kingdom, 3Department of Rheumatology, Mediclinic Parkview Hospital, Dubai, United Arab Emirates, 4Dr. Humeira Badsha Medical Center, Dubai, United Arab Emirates, 5Rajarajeswari medical College and hospital, Bangalore, India, 6Royal Wolverhampton Trust, Wolverhampton/University of Manchester, United Kingdom

Meeting: ACR Convergence 2022

Keywords: Disparities, gender

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Saturday, November 12, 2022

Title: Healthcare Disparities in Rheumatology Poster

Session Type: Poster Session A

Session Time: 1:00PM-3:00PM

Background/Purpose: The gender equity in academic rheumatology initiative has sparked discussions on the effect of inequity in academia on assignment to leadership roles. To explore whether a gender gap exists in the global rheumatology leadership, we undertook a cross-sectional review of gender representation among the presidents of regional leagues, and national organizations in Asia-Pacific.

Methods: The names and terms in office of current and past presidents, of 5 regional rheumatology leagues and 19 national rheumatology organizations were obtained from the official website of each organization. The binary gender of each president was estimated using the name-to-gender inference platform Gender-API. Proportions of male and female presidents were determined for each organization and compared for presidencies commencing before and in/after the year 2000. Differences in female representation over time were tested using Fisher’s exact test.

Results: The overwhelming majority of all the past and current presidents of regional rheumatology leagues (94%) and national rheumatology organizations were men (83%) (Table 1,2). 2/5 of regional rheumatology leagues and 7/19 of national rheumatology organizations had all-male presidents (Table 1,2). The proportion of female presidents increased in many leagues in/after the year 2000. However, the results were significant only for the American College of Rheumatology (ACR), and the 19 rheumatology organizations from Asia-Pacific when analyzed as a whole. (Table 3).

Conclusion: A gender gap in leadership seems to be prevalent in rheumatology globally, although trends indicate improvement in some regions in the past 2 decades. Regional rheumatology leagues and organizations should step forward to promote gender equity and overcome disparities.

Supporting image 1

Table 1. Number and proportion of male and female presidents in the regional rheumatology leagues.

Supporting image 2

Table 2: Number and proportion of male and female presidents in the national rheumatology organizations from the Asia-Pacific

Supporting image 3

Table 3: Estimated gender representation among the global rheumatology leadership by the organization and presidential terms in office commencing before and in/after 2000


Disclosures: T. Khursheed, None; P. Ovseiko, None; G. Harifi, None; H. Badsha, None; H. Shekar, None; L. Gupta, None.

To cite this abstract in AMA style:

Khursheed T, Ovseiko P, Harifi G, Badsha H, Shekar H, Gupta L. Closing the Gender Gap in Global Rheumatology Leadership- Are We There Yet? [abstract]. Arthritis Rheumatol. 2022; 74 (suppl 9). https://acrabstracts.org/abstract/closing-the-gender-gap-in-global-rheumatology-leadership-are-we-there-yet/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to ACR Convergence 2022

ACR Meeting Abstracts - https://acrabstracts.org/abstract/closing-the-gender-gap-in-global-rheumatology-leadership-are-we-there-yet/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology